Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  2. 4 Open-market sale Chief Medical Officer sold 10,000 shares at $2.22 ($22,200)
  3. 8-K Event Regulation FD disclosure
  4. 4 Grant or award Director acquired 5,958 shares (grant or award)
  5. 4 Grant or award Director acquired 7,513 shares (grant or award)
  6. EFFECT Other Notice of Effectiveness
  7. 424B5 Offering Prospectus
  8. CORRESP Other Correspondence Between Filers and SEC Staff
  9. S-3 Offering Registration Statement
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 4 Shares withheld for taxes Chief Scientific Officer gave up 5,644 shares (to pay taxes)
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 8-K Event Material agreement
  19. 424B5 Offering Prospectus
  20. FWP Offering Free Writing Prospectus

Page 4 of 28 · 548 filings